1. a Novartis company
Process Engineering and
Operational Excellence synergy:
a key driver for boosting cost savings and productivity results
Marcelo Costa
Pharma Talk, Pharmaceutical Manufacturing Excellence 2013
4 June 2013 Berlin, Germany
2. 2 Process Engineering and Operational Excellence synergy | Pharma Talk, Pharmaceutical Manufacturing Excellence 2013 | Berlin, Germany | 4 Jun 2013
About this presentation
The material presented today is an adaptation of the practical
experience of a local Continuous Improvement Program
integration into an established Process Engineering area which
both supported a Pharmaceutical plant to boost its Packaging
Area‟s objective of increasing productivity
• Purpose
• Deployment
• Achievements
3. 3 Process Engineering and Operational Excellence synergy | Pharma Talk, Pharmaceutical Manufacturing Excellence 2013 | Berlin, Germany | 4 Jun 2013
About this presentation
The case study presented today is about an oral solid plant...
Global
pressure
Local
pressure
COGS
Headcount
Service level
No Global approach for continuous
improvement
....
Pricing pressure
Generic players
Long production lead-times, low-level
agility
No local approach for continuous
improvement in place
....
4. 4 Process Engineering and Operational Excellence synergy | Pharma Talk, Pharmaceutical Manufacturing Excellence 2013 | Berlin, Germany | 4 Jun 2013
Contents
1) Introduction
2) Continuous Improvement Deployment
3) OEE TGT and Losses approach
4) OEE & Productivity
5) Throughput Time
6) Cost Savings initiative
5. 5 Process Engineering and Operational Excellence synergy | Pharma Talk, Pharmaceutical Manufacturing Excellence 2013 | Berlin, Germany | 4 Jun 2013
Contents
1) Introduction
2) Continuous Improvement Deployment
3) OEE TGT and Losses approach
4) OEE & Productivity
5) Throughput Time
6) Cost Savings initiative
6. 6 Process Engineering and Operational Excellence synergy | Pharma Talk, Pharmaceutical Manufacturing Excellence 2013 | Berlin, Germany | 4 Jun 2013
ExcellenceOptimizationPreventionStabilizationCorrective Action
Continuous Improvement – The Dilemma
a long but sustainable
journey ahead...
straight to
big wins!
Build-up in excellence
Sustainability
Short term focus
Contingency
Operational Process Performance
7. 7 Process Engineering and Operational Excellence synergy | Pharma Talk, Pharmaceutical Manufacturing Excellence 2013 | Berlin, Germany | 4 Jun 2013
Key Challenges
Scenario
Objective
Challenges
Increase plant capacity
How would we justify the
investment, and make sure
you got the right equipment?
How much extra capacity
could we find if we had less
losses?
What problems could be
resolved by bringing together
people from different teams?
Increasing volume forecast
Products insourcing to
increase supply flexibility and
allow Interco transfers
OEE did not meet capacity
needs, FTE reduction
pressure
8. 8 Process Engineering and Operational Excellence synergy | Pharma Talk, Pharmaceutical Manufacturing Excellence 2013 | Berlin, Germany | 4 Jun 2013
Contents
1) Introduction
2) Continuous Improvement Deployment
3) OEE TGT and Losses approach
4) OEE & Productivity
5) Throughput Time
6) Cost Savings initiative
9. 9 Process Engineering and Operational Excellence synergy | Pharma Talk, Pharmaceutical Manufacturing Excellence 2013 | Berlin, Germany | 4 Jun 2013
Integration towards Business Goals
Total Productive Maintenance (TPM)
implementation
Focused Improvement Pillar focused on
identifying losses, performance
indicators, actions prioritization and losses
reduction
Autonomous, Preventive Maintenance and
E&T Pillars focused on restore of basic
machine conditions, preventive plans and
staff training
Leadership on production lead time reduction
and other continuous improvement initiatives
OEE, performance metrics and standards for
product costing
Packaging Development: harmonization of
specifications, materials optimisation and
operational improvements
Yearly budget: OEE TGT and utilization with
optimized line allocation
Fine planning: best product sequence
Cost savings management across the site
Capital projects for Innovation & Technology
enhancement
OEE/ PRODUCTIVITY THROUGHPUT TIME
Reinforce OEE as the tool for
systemic Capital Asset freeing up
Identify the main causes of non-
productive time
Standards for costing
Output, material and headcount
optimization
Product allocation and sequence
Address the gap between bulk
production and packaging
Reduce bulk holding time
impacts
Synchronise support processes
Process Engineering Continuous Improvement
COST SAVINGS
Capital projects & new
technologies
Generate opportunities for
costing savings and investment
with attractive payback periods
within pilot areas as well as the
entire organization
10. 10 Process Engineering and Operational Excellence synergy | Pharma Talk, Pharmaceutical Manufacturing Excellence 2013 | Berlin, Germany | 4 Jun 2013
Continuous Improvement Deployment
Process Engineering
Focused
Improvement
Autonomous
Maintenance
Planned
Maintenance
Training and
Education
Office TPM
Site Continuous Improvement
DRIVE
Project
OEE/ PRODUCTIVITY –– THROUGHPUT TIME –– COST SAVINGS
11. 11 Process Engineering and Operational Excellence synergy | Pharma Talk, Pharmaceutical Manufacturing Excellence 2013 | Berlin, Germany | 4 Jun 2013
Contents
1) Introduction
2) Continuous Improvement Deployment
3) OEE TGT and Losses approach
4) OEE & Productivity
5) Throughput Time
6) Cost Savings initiative
12. 12 Process Engineering and Operational Excellence synergy | Pharma Talk, Pharmaceutical Manufacturing Excellence 2013 | Berlin, Germany | 4 Jun 2013
OEE
KPI to measure the overall
„health‟ of the Manufacturing
Operation and the key enabler
to increase capacity, and so
reduce capital requirements
OEE deployment: Should I measure the OEE of all work centers?
NO!
Identify the constraint operations of the
plant, because bottlenecks limit the
throughput of the entire system
Improvement to any of the other operations
is of no benefit to the total process
Actual Process output
Target Process output
Maximum potential output
13. 13 Process Engineering and Operational Excellence synergy | Pharma Talk, Pharmaceutical Manufacturing Excellence 2013 | Berlin, Germany | 4 Jun 2013
Losses Tree and Improvement Approach
Losses Attack &
Elimination:
Changeover Time
and Stoppages
Reduction
Unscheduled
downtime
Set up
Effective
Uptime
Adjustment
Breakdown/
Failure
Speed Loss
Minor
Interruptions &
Others
Free capacity
Unscheduled
downtime
Set up
Effective
Uptime
Adjustment
Breakdown/
Failure
Speed Loss
Minor Interruptions
& Others
Standard
Speed
Increase
Losses Attack & Elimination
increase availability by reducing speed
loss, stoppages and C/O time
Standard Speed Increase
reduce Effective Uptime by increasing Maximum
Validated Speed
Losses Tree is a systematic approach to speed
up loss detection and priority-set loss elimination
Losses
Trend
Analysis
Achievement of TGT OEE
State clearly the logic of why
you chose your projects:
“Seeing is Believing”
Improvement
Projects
Maintainance of TGT OEE:
Focused on identifying the
outliers and preventing
recurrence
14. 14 Process Engineering and Operational Excellence synergy | Pharma Talk, Pharmaceutical Manufacturing Excellence 2013 | Berlin, Germany | 4 Jun 2013
Bottleneck Analysis: Utilization Assessment
CAMBE FACILITIES FULL CAPACITY [ % ]
DISPENSING tons/year 64%
SMALL DISPENSING tons/year 66%
MIXING tons/year 66%
GRANULATION 300kg tons/year 65%
GRANULATION 30kg tons/year 72%
TABLETING mio/year 84%
CAPSULING mio/year 65%
COATING 300kg tons/year 88%
COATING 30kg tons/year 37%
BLISTERING mio/year 88% Little room for shifts increase
CARTONING mio/year 95% No room for shifts increase
655
108
63
88
316
265
4
264
6
315
417
58
208
171
51
CAMBE FACILITIES OVERVIEW
70
55
5
84
15
96
54
USED CAPACITYWORK CENTER
15. 15 Process Engineering and Operational Excellence synergy | Pharma Talk, Pharmaceutical Manufacturing Excellence 2013 | Berlin, Germany | 4 Jun 2013
TGT OEE and Improvement Plan
Line Utilization and TGT OEE setting:
OEE calculation based on last year losses
tree and volume forecast at SKU level
OEE challenged to achieve Target
Utilization level
Working groups defined according to
Losses Prioritization, Pareto stratification
and output increase projects
Lines with higher utilization to be
prioritized
16. 16 Process Engineering and Operational Excellence synergy | Pharma Talk, Pharmaceutical Manufacturing Excellence 2013 | Berlin, Germany | 4 Jun 2013
Contents
1) Introduction
2) Continuous Improvement Deployment
3) OEE TGT and Losses approach
4) OEE & Productivity
5) Throughput Time
6) Cost Savings initiative
17. 17 Process Engineering and Operational Excellence synergy | Pharma Talk, Pharmaceutical Manufacturing Excellence 2013 | Berlin, Germany | 4 Jun 2013
Packaging Optimization Cycle (1 of 2)
Set up stratification:
A: simplified cleaning
B: A + form/ sealing exchange
C: full cleaning w/o tooling exchange
D: C + form/ sealing exchange
E: blister size change
1) Product Allocation:
Optimize packaging lines thru reducing tooling
format changes:
– set up downtime
– material losses
– operators patience...
A
B
C
D
E
Find the right balance, useful rules:
• high machine output same blister size, low
blister per package ratio, high volume products
• low machine output high mix, low volume, but
evaluate “A or B” items allocated to ensure
beginning of the month production
Scenario 1: 1 blister format
(h) # average
Set Up A 252 234 1,1
Set Up B 54 32 1,7
Set Up C 10 6 1,6
Set Up D 226 91 2,5
Set Up E 0 0 0,0
541 363 1,7
Set Up Losses Tree: 14,8%
Scenario 2: 2 blisters format
(h) # average
Set Up A 252 234 1,1
Set Up B 54 34 1,6
Set Up C 10 5 2,0
Set Up D 113 45,5 2,5
Set Up E 273 45,5 6,0
701 364 2,6
Set Up Losses Tree: 19,1%
18. 18 Process Engineering and Operational Excellence synergy | Pharma Talk, Pharmaceutical Manufacturing Excellence 2013 | Berlin, Germany | 4 Jun 2013
Cartoner output is the mandatory
output of the entire line
180 blisters
minute
90 cartons
minute
divided by
2 blisters
carton
Before
divided by
1 blister
carton
180 blisters
minute
180 cartons
minute
After
Example:
10
tablets
per blister
3
blisters
per carton
Before
15
tablets
per blister
2
blisters
per carton
After
Packaging Optimization Cycle (2 of 2)
2) Blister Optimization:
Reduce the number of blister per finished
good at SKU level:
– increase output
– reduce material consumption
3) Secondary and Tertiary materials
A B C
54 x 30 x 120
54 x 44 x 120
19. 19 Process Engineering and Operational Excellence synergy | Pharma Talk, Pharmaceutical Manufacturing Excellence 2013 | Berlin, Germany | 4 Jun 2013
Capital Projects for productivity increase
FB insertion into SB
What: new semi-automatic case packer along with packaging
material harmonization (from 3 FBs and 3 SBs to 1 FB and 1
SB) and optimization (FB positioning into SB according to Case
Packer working sequence)
Why: reduction of one extra end-of-line FTE per shift
Leaflet
Folding Box
Shipping Box
Blister
Case packer
How would you justify
the investment, and
make sure you got the
right equipment?
20. 20 Process Engineering and Operational Excellence synergy | Pharma Talk, Pharmaceutical Manufacturing Excellence 2013 | Berlin, Germany | 4 Jun 2013
Identify, prioritize and attack losses through root cause analysis (CAPDo)
Focused Improvement
C
A P
D
High minor stoppages,
further analysis
revealed several short
adjustments
Focus group
Causes:
• Bulk clogging
• Wrong unclogging
procedure leading to
feeder tubes damage
• Unstable bulk
process control
(height)
• Vibration system not
working
• Occurrence of
damaged plugs
Actions:
• Revised preventive
plan according to new
findings
• Revised spare parts
list
• Bulk troubleshooting
• OPL training
23,4 down to 17,6 %
15,4 down to 8,0 %
How much extra
capacity could we
find if we had less
losses?
Feeding System as
the main cause
21. 21 Process Engineering and Operational Excellence synergy | Pharma Talk, Pharmaceutical Manufacturing Excellence 2013 | Berlin, Germany | 4 Jun 2013
Implement countermeasures
and follow up
Remove dust and dirt on and
around the equipment to ensure
basic GMP rules and enable
inspection
Identify and inspect:
Flaws
Basic Conditions
Hard to access areas
Sources of contamination
Safety
Lubrication points
Surrounding area
Cleaning
Inspection
Countermeasures
Abnormalities mapping
Flaws, Basic Conditions and
Safety abnormalities
identified and recorded
Establish the
basic
conditions to
maintain
equipment
performance
23
4 1
Establishing simple and quick mechanisms for addressing and
solving problems by everyone, before they occur
Enabling people to work and think at the same time!
Autonomous Maintenance
SC - Sources of Contamination
HRA - Hard to Reach Areas
Hard to Reach Areas
Sources of Contamination
A
B
E
E
D
CB
0
0
A
0
C
H
0
D
0
0
0
G
0 0
0
D
22. 22 Process Engineering and Operational Excellence synergy | Pharma Talk, Pharmaceutical Manufacturing Excellence 2013 | Berlin, Germany | 4 Jun 2013
AM achievements
Basic Principles of GMP:
Avoidance of cross-contamination and mix-
ups
HSE Risk Identification:
elimination of safety failures
23. 23 Process Engineering and Operational Excellence synergy | Pharma Talk, Pharmaceutical Manufacturing Excellence 2013 | Berlin, Germany | 4 Jun 2013
AM achievements
One Point Lesson: preventing errors and multiplying knowledge
Correct vs. Incorrect: variable data assembling Correct vs. Incorrect embossing station set up
24. 24 Process Engineering and Operational Excellence synergy | Pharma Talk, Pharmaceutical Manufacturing Excellence 2013 | Berlin, Germany | 4 Jun 2013
Pilot Lines Results
Line 4: first TPM line
+68%
OEE: 30 to 50%
+80%
Output: 1.500 to 2.700 packs/h
+47%
OEE: 26 to 39%
+56%
Output: 900 to 1.400 packs/h
Line 5: start up in Feb, first line with Early
Management approach
25. 25 Process Engineering and Operational Excellence synergy | Pharma Talk, Pharmaceutical Manufacturing Excellence 2013 | Berlin, Germany | 4 Jun 2013
Overall Packaging Results
OEE and productivity:
+23%
OEE: 40,8 to 50,1%
Productivity: 0,39 to 0,49
mio packs/ FTE
+24%
Blister Optimization:
• 27 SKUs completed represent a
significant improvement in sustainable
packaging versus the packaging
solutions that before existed
Cost
savings
USD 201.200
Material
reduction
3,3 tons aluminum (lidding material)
7,7 tons PVC | 12.9 tons PVdC (forming
material)
Packaging
weight
reduction
SKUs specific: -9% for Trilax c/12 (3,6
tons/year);
-5% for Doxuran 30 FCT (1 ton/year)
GHG
emissions
transport
1,0 ton CO2e (from natural material only)
Other
savings
Waste reduction, improved packaging lead-
time and energy avoidance
26. 26 Process Engineering and Operational Excellence synergy | Pharma Talk, Pharmaceutical Manufacturing Excellence 2013 | Berlin, Germany | 4 Jun 2013
Contents
1) Introduction
2) Continuous Improvement Deployment
3) OEE TGT and Losses approach
4) OEE & Productivity
5) Throughput Time
6) Cost Savings initiative
27. 27 Process Engineering and Operational Excellence synergy | Pharma Talk, Pharmaceutical Manufacturing Excellence 2013 | Berlin, Germany | 4 Jun 2013
Throughput Time
Elapsed time from material issue to Quality release of finished product
buffer
Scenario
Objective
Improve
systematically the
planning process
Not stable production
planning
High TpT numbers
Increasing
High inventory levels
Increased complexity
(e.g. batch re-
analysis)
28. 28 Process Engineering and Operational Excellence synergy | Pharma Talk, Pharmaceutical Manufacturing Excellence 2013 | Berlin, Germany | 4 Jun 2013
Process Flow and Areas of Opportunity
Setor Pontos Críticos Documentação Fluxo Procedimento
Chegada defasada das documentações (produção, embalagem e CQ) x
Gargalo no acúmulo de documentação (tempo ocioso X picos de demanda) x
Stock Out, interrompendo o fluxo de trabalho x
Fluxo inadequado na Informação da data de validade do lote x
Tempo excessivo para o encerramento dos desvios e ocorrências x
Demora dos outros setores na correção dos documentos x
Preenchimento incorreto da documentação - Sandoz x
Preenchimento incorreto da documentação - Terceiros x
Revisão da doc muito abrangente, não permitindo uma análise profunda pelo setor acarretando na
passagem do erro para o próximo revisor
x
Controle de devolução de lotes de bulk para a Produção no caso de retrabalho x
Stock out (quebra da programação) x
Programação Embalagem: não recebe bulk no momento programado x
Material sem custeio (financeiro) x
Fluxo inadequado na Informação da data de validade do lote x
Erros na configuração da documentação (PDF), ex: número de dígitos menor que o necessário x
Inexistência da FT x
Falta de material na linha: estrutura incorreta x
Falta de material na linha: baixa performance da linha de embalagem x
Falta de material na linha: sem material para reposição da linha no estoque x
Falta de material no estoque acarretando mudança na programação x
Falta de material na linha: erro na pick list, quantidade reservada errada x
Fechamento "virtual", acarreta em um esforço extra de liberação parcial, ajuste de saldo x
Descrição do código do material incorreto (IFT com estrutura) x
Material na secundária incorreto (tamanho, tipo de bula ou cartucho) em relação à estrutura x
Secundária tem que realizar reconciliação do documento da primária antes do apontamento
Aguardar reconciliação do documento da primária para apontamento x
Reconciliação de documentação: falta de campos assinados x
Reconciliação de documentação: divergência na quantidade de material x
Material em QT na hora do apontamento x
Aluminio Impresso em QT na hora do apontamento x
Estrutura do produto não "respeita" a alocação x
Documentos com o mesmo tipo de grandeza porém cada um com uma unidade diferente ex: kg e g x
Ajuste de estoque: fluxo financeiro x
Falta de ferramental x
Ajuste de estoque:diferença entre a necessidade e o tam do lote padrão do cliente x
Atraso na geração do documento mestre (produtos novos ou alterações) x
Falta de material na pesagem: erro na pick list, quantidade reservada errada x
Ajuste de estoque:diferença entre a necessidade e o tam do lote padrão do cliente x
Erro na quantidade/ falta de material na pick list x IFP x
Ausência de MP dentro da área de pesagem (pick list correta) x
EPI adequados para situações ou produtos novos x
MP vencida (no momento da reserva estava ok) x
MP com problemas de qualidade x
Ajuste de estoque: fluxo financeiro x
Material sem custeio (financeiro) x
Custeio incorreto do produto (refazer processo IFS) x
Falta de material "não consumível" ex: sacos plásticos, lacre x
Falta de fração no pallet (pesagem, granulação, mistura) x
Inserção de dado incorreto no relatório (equipamento mistura) x
Perda de material pelo operador ou perda de material no bin x
Documentação: erro de transcrição x
Documentação: etiqueta, pesagem, assinatura x
Stock out (quebra da programação) x
Erros no preparo das "soluções" x
Erro na transcrição de informação (documentação CQ) x
Erro no input de dados (HPLC) x
Falta de reagentes x
Organização: MP analisadas junto com a ser analisadas etc... x
Impressão do método em toda a análise (perda de papel) x
Stock Out, interrompendo o fluxo de trabalho x
Perda da documentação x
OSS identificada apenas na reconciliação da documentação x
Gargalo de documentação no fechamento do laudo
Assuntos que deveriam ser vistos antecipadamente
Erros operacionais
Erros em documentos (treinamento, mudança no doc, etc)
Organização
Fluxo entre clientes (internos ou externos)
Planejamento/ Programação
Finanças
GQ
Embalagem
Produção
CQ
Staging Bulk Prod. QC Packaging QA
Waste
does not add any value
to a product
Incidental activity
Work that does not directly
add customer value, but
which is currently necessary
to maintain
Value-added activity
Work that directly increases
the value of the product
Opportunity Areas
1. Production Flows
2. Administrative
Flows
3. Material Flows
4. Documentation
43%
54%
3%
29. 29 Process Engineering and Operational Excellence synergy | Pharma Talk, Pharmaceutical Manufacturing Excellence 2013 | Berlin, Germany | 4 Jun 2013
Synchronisation between end of manufacturing and packaging
Optimised sequence of orders - “packaging point of view” (pacemaker)
1. Production Flow Improvements
Production Control
Monthly planning
Dispensing
I I I
Granulation Tableting Packaging
Packaging
Pacemaker
Process
Production Control
Monthly planning
oxox
oxox
Dispensing Granulation Tableting
II I
1) High lead-time
2) Bulk capacity >
packaging
30. 30 Process Engineering and Operational Excellence synergy | Pharma Talk, Pharmaceutical Manufacturing Excellence 2013 | Berlin, Germany | 4 Jun 2013
Collaborative Planning Process with weekly reviews
• at SKU level – what, when, who and why!
2. Administrative Flow Improvements
31. 31 Process Engineering and Operational Excellence synergy | Pharma Talk, Pharmaceutical Manufacturing Excellence 2013 | Berlin, Germany | 4 Jun 2013
Packaging
room
3. Material Flow Improvements
Buffer between Manufacturing and Packaging was organized so that the bulk
operator should park the pallet in the correct line according to the product
allocation in Packaging
Then, the packaging material from Staging is to be placed according to bulk
position
32. 32 Process Engineering and Operational Excellence synergy | Pharma Talk, Pharmaceutical Manufacturing Excellence 2013 | Berlin, Germany | 4 Jun 2013
4. Documental improvements
Finished good data-sheet simplification
As is
After
Improvement
Result D%
Checking items 13 8 - 5 - 38,5%
Page numbers 11 4 - 7
- 63,6%
Pages per year 13.200 4.800 - 8.400
33. 33 Process Engineering and Operational Excellence synergy | Pharma Talk, Pharmaceutical Manufacturing Excellence 2013 | Berlin, Germany | 4 Jun 2013
TpT Results
400
600
800
1000
1200
1400
1600
1800
2000
WorkingProcess(kUSD)
PY ACT
-40%
950
960
970
980
990
1000
1010
1020
1030
1040
Volume(kbulkunits)
PY ACT
5%
-67%
TpT: 85,6 to 27,9 days
On time % (orders released on TGT): 30 to 71% +136%
34. 34 Process Engineering and Operational Excellence synergy | Pharma Talk, Pharmaceutical Manufacturing Excellence 2013 | Berlin, Germany | 4 Jun 2013
Contents
1) Introduction
2) Continuous Improvement Deployment
3) OEE TGT and Losses approach
4) OEE & Productivity
5) Throughput Time
6) Cost Savings initiative
35. 35 Process Engineering and Operational Excellence synergy | Pharma Talk, Pharmaceutical Manufacturing Excellence 2013 | Berlin, Germany | 4 Jun 2013
DRIVE Project
A global program that focuses on the tracking and reporting of cost
improvements
What problems could
be resolved by
bringing together
people from different
teams?
36. 36 Process Engineering and Operational Excellence synergy | Pharma Talk, Pharmaceutical Manufacturing Excellence 2013 | Berlin, Germany | 4 Jun 2013
COGS reduction
0.28
0.02
0.45
Total Bulk
2.43
Total Bulk
2.15
Total Bulk
2.13 Total Bulk
1.69
0
1
1
2
2
3
3
Manufacturing Breakdown
0.05 0.01 0.09Pack 0.44 Pack 0.39 Pack 0.38 Pack 0.290
1
1
2
2
3
3
Baseline Short-term… Short-term… Mid-term…
Packaging Breakdown
0.33
0.03
0.53
TPC
2.87 TPC
2.54
TPC
2.51 TPC
1.98
0
1
1
2
2
3
3 Product Cost Evolution
• API Price negotiation
• Yield Factor increase
• Opadry scrap reduction
• Reduced Coating
processing time
• Batch size increase
• New API supplier
• Forming foil: new supplier
under development
• Lidding foil: 21 microns to 25
• Leaflet: New Supplier BID2012
37. 37 Process Engineering and Operational Excellence synergy | Pharma Talk, Pharmaceutical Manufacturing Excellence 2013 | Berlin, Germany | 4 Jun 2013
Bulk Production
What: automatic CIP detergent re-filling
Why: “always had been done” manually
by 2 operators
Maintenance
What: calibration station for up to 8
equipment simultaneously
Why: speed up calibration task
previously done one after other
Initiatives across areas (1 of 3)
38. 38 Process Engineering and Operational Excellence synergy | Pharma Talk, Pharmaceutical Manufacturing Excellence 2013 | Berlin, Germany | 4 Jun 2013
Logistics In-bound
What: optimized layout and material flow
layout for sampling
Why: QC analysts spent much time
searching for materials to sample
IT
What: 2S (Sort + Set in order) in Data
Storage for 100% of associates
Why: TechOps used to pay USD 95k
for data storage (almost 1 Tb) and
storage quota was almost exhausted
400
500
600
700
800
900
1000
DataStorage(GB)
Kick Off End of 2S's
-34%
Initiatives across areas (2 of 3)
39. 39 Process Engineering and Operational Excellence synergy | Pharma Talk, Pharmaceutical Manufacturing Excellence 2013 | Berlin, Germany | 4 Jun 2013
Initiatives across areas (3 of 3)
Utilities
What: Energy Management based on PDCA mindset
Why: offset production growths, pursue energy cost savings whilst reducing CO2
emissions
2007
2008
2009
2010
2011
2012
26,000
27,000
28,000
29,000
30,000
31,000
32,000
33,000
0 500 1,000 1,500
EnergyinGJ
mio SDU
Energy Trend:
Production vs. Consumption
Trend before EM*
*EM = Energy Management started in mid 2010 Trend first 2 yrs.
Trend after 2 yrs.
40. 40 Process Engineering and Operational Excellence synergy | Pharma Talk, Pharmaceutical Manufacturing Excellence 2013 | Berlin, Germany | 4 Jun 2013
Takeaways
Do not wait for a Global approach to start your journey into
Excellence, but it would help
Do not ask your staff “what can we do better”, give them a structured
way where they need to work on
Do not only rely on a few well-intentioned people to sustain your
journey, it must be part of your Company‟s “Values and Behaviors”
Do not only design your Continuous Improvement program inside a
room, it must be fine-tuned together with your operational area
Be careful with the bad apples, and believe in it, some of them are
probably sitting at your table.
41. 41 Process Engineering and Operational Excellence synergy | Pharma Talk, Pharmaceutical Manufacturing Excellence 2013 | Berlin, Germany | 4 Jun 2013
Thank you! Vielen Dank!
For further feedback, questions and
suggestions please contact
marcelo.costa_rodriguez@sandoz.com
+49 39203 71-6762